Roche's VENTANA MMR RxDx Panel: A New Era in Arizona Cancer Diagnostics with IVDR Approval

Used as a predictive biomarker, the first-of-its-kind VENTANA MMR RxDx Panel helps identify cancer patients eligible for treatment with certain precision oncology therapiesBy evaluating a panel of MMR proteins in tumours, the test provides clinicians with a standardised testing option…